Canagliflozin : A Novel SGLT2 Inhibitor in T2D Management with CV and Renal Benefits
May 9 , 2018 | นพ.ปริญญ์ วาทีสาธกกิจ
- 1479
- 0
- 3
Canagliflozin : A Novel SGLT2 Inhibitor in T2D Management with CV and Renal Benefits
May 9 , 2018 | นพ.ปริญญ์ วาทีสาธกกิจ
Canagliflozin : A Novel SGLT2 Inhibitor in T2D Management with CV and Renal Benefits